ThredUp Achieves Record Q2 2025 Results!
ThredUp announces stellar Q2 2025 financial results with record revenue, exceptional new buyer growth, and raised full-year outlook, driven by AI and thrifting trends.
ThredUp announces stellar Q2 2025 financial results with record revenue, exceptional new buyer growth, and raised full-year outlook, driven by AI and thrifting trends.
Vertex Pharmaceuticals' stock fell after its pain drug VX-993 failed a trial. Despite this, Q2 earnings exceeded estimates, driven by cystic fibrosis drugs. Journavx also faces FDA limitations.
Hims & Hers' Q2 profit surged to $42.5M, fueled by 31% subscriber growth (2.4M total). Revenue of $544.8M missed estimates, impacted by wholesale weakness, causing shares to fall. Full-year guidance maintained.
Palantir's Q2 2025 results show strong AI-driven growth. Revenue hit $1.004B, US commercial up 93%, US revenue up 68%. FY25 guidance raised.
President Trump's endorsement of GOP actress Sydney Sweeney's "hottest" American Eagle ad led to a significant stock jump and brief meme status, despite campaign criticism.
Joby Aviation acquired Blade's urban air mobility passenger business (US/Europe) for up to $125M. This gives Joby market access, infrastructure, and customers, accelerating their electric air taxi commercialization. Shares of both companies surged on the news.